It is however not difficult to understand the market potential and reach of a product like Aulprofem but we will like to restrict ourselves to conservative estimates. To discuss a few points:

1. Seiel and Amann estimate: Seidel G.E. and Amann,R.P. in an article titled ’The impact of using sexed semen’{ in Prospects for Sexing Mammalian Sperm. 1982. R.P.Amann and G .E.Seidel, Jr. (eds.). Boulder, Colorado. Colorado University Associated Press} has calculated the American market to be around $30 million a year for an economical discovery producing female sexed off-springs. The actual market can be a little more or less provided that these things can only be judged on the actual entry of such a product in the market.2. Indian Market: India has a central dairy ministry and state dairy ministries in addition to the National Dairy Development Board(NDDB) which are well organized and massive organizations to manage its huge animal wealth of 280 million cows and buffaloes. They conduct about 1.5 to 2 crore AI’s(Artificial Inseminations) every year. This simply means the existence of a market of a near 1.5 to 2 crore doses per year. Calculated at the ate of Rs.295 pr dose this amounts to a market of nearly 440 to 590 crores of rupees per year. The usual rural and other dairy market is different and to add to this. So, the total market for a product like Aulprofem can be believed to be a considerable one . The markets for other animals like horses, sheep, goats, pigs, dogs, etc. is different. So, it can be inferred that the cumulative market for Aulprofem can be considerable. The only question is to tap it efficiently and systematically.3. Off-shore Market : Off-shore market that exists in Europe and other countries is huge and can be expected to run into hundreds of millions in dollars. The patent rights of Aulprofem are protected in U.S.A., Canada, Australia, New Zealand, South Africa and nearly 21 countries of Europe. So, a combined market for all of these countries can be expected to be a much bigger one.